| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Dermatology and Emory Skin Disease Research
Core Center*
and the Department of
Pathology,
Emory University School of
Medicine, Atlanta, Georgia; the Laboratory for Surgical
Research,
Department of Surgery,
Harvard Medical School and Children’s Hospital, Boston, Massachusetts;
and the Department of Adult Oncology,§
Dana
Farber Cancer Institute, Boston, Massachusetts
Activated ras causes increased activity of several signal transduction systems, including the mitogen-activated protein kinase kinase (MAPKK) pathway and the phosphoinositol-3-kinase (PI-3-K) pathway. We have previously shown that the PI-3-K pathway plays a major role in regulation of ras-mediated tumor angiogenesis in angiosarcoma cells. However, the contribution of the MAPKK pathway to tumorigenesis and angiogenesis is not fully understood. Overexpression of constitutively active forms of MAPKK has previously been shown to transform nonmalignant NIH3T3 fibroblasts, but the effect of down-regulation of MAPKK on tumorigenesis and angiogenesis in a well established tumor has not been fully explored. We introduced a dominant negative MAPKK gene into SVR murine angiosarcoma cells. Introduction of a dominant negative MAPKK causes a significant decrease in proliferation rate in vitro and morphological reversion. Cells expressing the dominant negative MAPKK have a greatly decreased ability to form colonies in soft agar compared with wild-type cells. Despite the decreased cell growth in vitro and inability to grow in soft agar, the cells were equally tumorigenic in nude mice. Our results suggest that the MAPKK pathway is required for soft agar growth of angiosarcoma cells, and separates the phenotypes of soft agar growth versus in vivo tumorigenicity. These findings have implications in the development of signal transduction modulators as potential antineoplastic agents.
This article has been cited by other articles:
 |
|
 |
|
  B. Perry, J. Banyard, E. R. McLaughlin, R. Watnick, A. Sohn, D. N. Brindley, T. Obata, L. C. Cantley, C. Cohen, and J. L. Arbiser AKT1 Overexpression in Endothelial Cells Leads to the Development of Cutaneous Vascular Malformations In Vivo Arch Dermatol, April 1, 2007; 143(4): 504 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Arbiser, T. Kau, M. Konar, K. Narra, R. Ramchandran, S. A. Summers, C. J. Vlahos, K. Ye, B. N. Perry, W. Matter, et al. Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis Blood, January 15, 2007; 109(2): 560 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Perry, C. Cohen, B. Govindarajan, G. Cotsonis, and J. L. Arbiser Wilms tumor 1 expression present in most melanomas but nearly absent in nevi. Arch Dermatol, August 1, 2006; 142(8): 1031 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cerimele, T. Battle, R. Lynch, D. A. Frank, E. Murad, C. Cohen, N. Macaron, J. Sixbey, K. Smith, R. S. Watnick, et al. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma PNAS, January 4, 2005; 102(1): 175 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Lu, J. L. Arbiser, J. West, M. Hoedt-Miller, A. Sheridan, B. Govindarajan, J. W. Harral, D. M. Rodman, and B. Fouty Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Can Induce Apoptosis in Subsets of Premalignant Cells Am. J. Pathol., November 1, 2004; 165(5): 1613 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cerimele, L. F. Brown, F. Bravo, G. M. Ihler, P. Kouadio, and J. L Arbiser Infectious Angiogenesis: Bartonella bacilliformis Infection Results in Endothelial Production of Angiopoetin-2 and Epidermal Production of Vascular Endothelial Growth Factor Am. J. Pathol., October 1, 2003; 163(4): 1321 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Bai, F. Cerimele, M. Ushio-Fukai, M. Waqas, P. M. Campbell, B. Govindarajan, C. J. Der, T. Battle, D. A. Frank, K. Ye, et al. Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo J. Biol. Chem., September 12, 2003; 278(37): 35501 - 35507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Govindarajan, M. C. Mizesko, M. S. Miller, H. Onda, M. Nunnelly, K. Casper, D. Brat, C. Cohen, and J. L Arbiser Tuberous Sclerosis-associated Neoplasms Express Activated p42/44 Mitogen-activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth Clin. Cancer Res., August 1, 2003; 9(9): 3469 - 3475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Govindarajan, X. Bai, C. Cohen, H. Zhong, S. Kilroy, G. Louis, M. Moses, and J. L Arbiser Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling J. Biol. Chem., March 7, 2003; 278(11): 9790 - 9795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cohen, A. Zavala-Pompa, J. H. Sequeira, M. Shoji, D. G. Sexton, G. Cotsonis, F. Cerimele, B. Govindarajan, N. Macaron, and J. L. Arbiser Mitogen-actived Protein Kinase Activation Is an Early Event in Melanoma Progression Clin. Cancer Res., December 1, 2002; 8(12): 3728 - 3733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Arbiser, B. Govindarajan, X. Bai, H. Onda, A. Kazlauskas, S. D. Lim, M. B. Amin, and L. Claesson-Welsh Functional Tyrosine Kinase Inhibitor Profiling : A Generally Applicable Method Points to a Novel Role of Platelet-Derived Growth Factor Receptor-{beta} in Tuberous Sclerosis Am. J. Pathol., September 1, 2002; 161(3): 781 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Duesbery, J. Resau, C. P. Webb, S. Koochekpour, H.-M. Koo, S. H. Leppla, and G. F. Vande Woude Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways PNAS, March 16, 2001; (2001) 61031898. [Abstract] [Full Text]
|
|
|
|
|
|
N. S. Duesbery, J. Resau, C. P. Webb, S. Koochekpour, H.-M. Koo, S. H. Leppla, and G. F. Vande Woude Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways PNAS, March 27, 2001; 98(7): 4089 - 4094. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
